EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,673 | -18.9% | 867 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $16,854 | -31.5% | 867 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,597 | -15.7% | 867 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $29,166 | +32.6% | 867 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | -42.1% | 867 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $38,000 | -11.6% | 867 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $43,000 | -2.3% | 867 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $44,000 | -8.3% | 867 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $48,000 | +29.7% | 867 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $37,000 | +2.8% | 867 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $36,000 | -10.0% | 867 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $40,000 | +8.1% | 867 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $37,000 | -11.9% | 867 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $42,000 | +5.0% | 867 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $40,000 | -23.1% | 867 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $52,000 | +6.1% | 867 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $49,000 | +2.1% | 867 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $48,000 | +9.1% | 867 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $44,000 | +25.7% | 867 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $35,000 | -41.7% | 867 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $60,000 | -9.1% | 867 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $66,000 | +69.2% | 867 | +16.1% | 0.00% | +50.0% |
| Q1 2018 | $39,000 | -2.5% | 747 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $40,000 | 0.0% | 747 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $40,000 | -32.2% | 747 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $59,000 | +7.3% | 747 | +12.8% | 0.00% | 0.0% |
| Q1 2017 | $55,000 | – | 662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |